Insulin aspart: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
← Older editNewer edit →
No edit summary
Michal Harel (talk | contribs)
31,761 edits
No edit summary
Line 1: Line 1:
<StructureSection load='' size='340' side='right' caption='PDB ID [[4gbc]]' scene='96/968809/Cv/3'>
<StructureSection load='' size='340' side='right' caption='Human modified insulin complex with cresol Zn+2 and Cl-; PDB ID [[4gbc]]' scene='96/968809/Cv/3'>
Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart] and [[Insulin]].
Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart] and [[Insulin]].


Revision as of 12:57, 17 January 2024

Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [1] and Insulin.

(PDB ID 4gbc).


Human modified insulin complex with cresol Zn+2 and Cl-; PDB ID 4gbc

Drag the structure with the mouse to rotate

ReferencesReferences

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel
Retrieved from "https://proteopedia.openfox.io/wiki/index.php?title=Insulin_aspart&oldid=4018700"